AREVA logo

Successful completion of AREVA’s capital increase reserved for Investments Certificates holders

Press release

GROUP / FINANCE

January 25, 2011

AREVA announces that it has successfully completed the 35-million euro capital increase reserved for investment certificate (IC) holders that was launched on January 3 and closed on January 14, 2011. It followed the capital increase reserved for Kuwait Investment Authority (KIA) and the French State. These operations allowed the group to raise a cumulated amount of 935 million euros.

1,085,535 new shares were subscribed by irrevocable entitlement (à titre irréductible) i.e. a subscription rate of 91.15%.

This capital increase allows public investors to maintain their 4.0% share in AREVA’s capital. Settlement and delivery of the new preferred shares without voting right and their listing on the regulated market of NYSE Euronext in Paris (Segment B) will occur on January 27, 2011. The new shares will be issued cum dividend and will accordingly be entitled to all dividends declared as of this date. They will be listed under the distinct ISIN code FR0010986190. As of January 27, 2011, the total number of AREVA securities (ordinary shares, investment certificates, preferred shares without voting right) will be increased to 383,204,852. The table below shows the percentage of share capital and voting rights owned by all types of security holders:

Holders
of AREVA
securities
CEA*French
state
KIACDC**EDF
Group
CA
CIB***
Total
Group
Fram
epargne
AREVA
Treasury
shares
Public
% capital 73,010,24,83,32,20,90,90,40,24,0
% voting rights77,110,24,83,32,20,90,90,4--

Avertissement

*    Commissariat à l’Energie Atomique et aux énergies alternatives
**   Caisse des Dépôts et Consignations
***  Crédit Agricole Corporate and Investment Banking

Disclaimer

Not for distribution, directly or indirectly, in or into the United States, Canada, Australia or Japan.

The distribution of this press release may be restricted by law in certain jurisdictions. Persons into whose possession this document comes are required to inform themselves about and to observe any such restrictions.

This press release and the information contained herein in no way represent an offer of securities for sale nor the solicitation of an offer to purchase securities, in the United States or any other country.

Securities may not be offered or sold in the United States unless they are registered under the U.S. Securi-ties Act of 1933, as amended or exempt from registration. The investment certificates without voting rights, the non-voting preferred shares and the preferential subscription rights of AREVA have not been and will not be registered under the U.S. Securities Act and AREVA does not intend to make a public offer of its securities in the United States. Copies of this document are not being, and should not be, distributed in or sent into the United States.

The distribution of this press release (which term shall include any form of communication) is restricted pursuant to section 21 (restrictions on financial promotion) of Financial Services and Markets Act 2000 ("FMSA"). In relation to the United Kingdom, this document is only being distributed to, and is directed only at, persons (i) who have professional experience in matters relating to investments falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion Order) 2005, as amended (the "Order"), (ii) falling within Article 49(2) (a) to (d) of the Order and (iii) to whom it may otherwise lawfully be distributed (all such persons together with Qualified Investors (as defined in Pro-spectus Directive) being referred to as "relevant persons").

This document must not be acted on or relied on in the United Kingdom by persons who are not relevant persons. Any investment or investment activity to which this document relates is available only in the United Kingdom to relevant persons, and will be engaged in only with such persons. By receiving this document you are deemed warrant to the Com-pany that you fall within the categories of persons described above.

Contact

  • AREVA Press Office:
    Julien Duperray / Katherine Berezowskyj / Aurélie Grange / Jérôme Rosso 
    Tel: +33 1 34 96 12 15 - Fax: +33 1 34 96 16 54
    email: press@areva.com

  • AREVA Investors Relations:
    Manuel Lachaux
    Anne-Sophie Jugean
    Tél : +33 1 34 96 11 53
    email: manuel.lachaux@areva.com